Lombard Medical Technologies Share Discussion Threads

[pelleeds1980] 06/10/2010 13:04

Hey jab also a stale bull here, been in for a while, nice to see some good news though and hope you're well.

Saw you posting on the CNR thread also managed to get in there a while ago.

[jab118] 06/10/2010 12:49

UK

lots of shares, need good volume to lift it, but that Japanese news is good to hear...

Alright nod you still in these then mate ?

[ukmassy] 06/10/2010 11:35

Is this share being held back? There are way more buys then sells!

[philo124] 06/10/2010 11:10

Greetings. The 400k just below 1p was mine and it was a BUY.

[nod] 06/10/2010 10:59

39 new jobs supported by £297,000
that's 7,615 each

Anyway... it looks like a clever deal with the Japanese. A big rich market. The loan will be forgiven if the agreement is extended. The local partner applies for approval.

[rayrac] 06/10/2010 10:00

The sells are in fact buys, some mine!

[joeblogg2] 06/10/2010 10:00

Real shame there are sellers which is surprising as most money raised has been at 1p or more!!!

[today7] 06/10/2010 09:56

Lombard Medical Tech' awarded £200,000 grant to support Prestwick manufacturing operation
Tuesday, September 07, 2010 by Jamie Ashcroft Lombard is rolling-out Aorfix in Europe, whilst also preparing for a launch into the important US market.
Lombard Medical Technologies (LON:LMT) has been awarded a £200,000 grant from Scotland's main economic development agency, as it relocates stent graft production to its facility in Prestwick, Ayrshire.

"The grant will allow us to focus important elements of our worldwide production in Scotland, and to benefit from the existing talent pool, advantageous cost base and the ability to scale up production to meet growing international demand", Lombard chief executive John Rush commented.

The company recently announced plans to relocate the production of stent grafts from Didcot in England to its existing Prestwick facility.
Proactiveinvestors recommends
Deltex: growth from medical consumablesAfrican Medical gains further momentum in medical insurance market with Interhealth dealPo Valley celebrates maiden production of one million cubic metres of gas in Italy According to Lombard, the subsequent capacity increase at Didcot will boost the assembly and loading of the delivery device for its lead product, the Aorfix endovascular stent graft.

Rush said, "the strategic reorganisation of our operations in Prestwick and Didcot will ensure the most effective use of our facilities."

The company highlighted that Aorfix is the only endovascular stent graft licensed in Europe to treat abdominal aortic aneurysms with neck angulations up to and including 90 degrees.

Lombard is rolling out Aorfix in Europe, whilst also preparing for a launch into the important US market.

In Europe it is focusing on five core markets: the UK, France, Germany, Italy and Spain. In the first half of 2010, Aorfix sales jumped 79% to £622,000 in the key European markets.

Meanwhile in the US, it is concluding phase III clinical trials. Recently Rush said the company is 'on track' to submit for regulatory approval in the US in the first half of next year.

The decision to restructure its operations is intended to support this growth. It is anticipated that the reorganised manufacturing structure will reduce costs and increase capacity over time, and therefore support the expansion.

The £200,000 Regional Selective Assistance (RSA) grant, awarded by Scottish Enterprise, will be paid in four instalments, each of which is dependent upon the company achieving specific milestones in its plans for Prestwick.

It is anticipated that the majority of the award will be received during 2011 and 2012.

[hope67] 06/10/2010 09:53

Bought small amount for sipp

[today7] 06/10/2010 09:51

price tgts anyone with this news

[today7] 06/10/2010 09:48

buying at 0.99 but very difficult

[moreforus] 06/10/2010 09:35

keya ..overhang cleared at 1p

4 mill buys on lse ..plus plus!

[keya5000] 06/10/2010 09:33

Just got myself some, looks like it may fly this one.

Hope there is no seller in the wings to ruin our fun here today.

[moreforus] 06/10/2010 09:32

2 vs 1

all stock gone (-;

mms poked

[topinfo] 06/10/2010 09:25

*DJ Lombard Medical Tech Re Agreement

(END) Dow Jones Newswires

October 06, 2010 04:23 ET (08:23 GMT)

Copyright (c) 2010 Dow Jones & Company, Inc.

TIDMLMT

RNS Number : 9360T

Lombard Medical Technologies PLC

06 October 2010

?

Lombard Medical Technologies PLC

("Lombard Medical" or "Company")

Lombard Medical signs Distribution Agreement for Aorfix(TM) in Japan

London, UK, 6 October 2010 - Lombard Medical Technologies PLC (AIM: LMT), a medical device company focused on solutions for the $1 billion abdominal aortic aneurysm (AAA) repair market, today announces that it has signed an agreement for the distribution of Aorfix(TM) in Japan, a new geographic market for Lombard Medical.

Japan is a major market for AAA stent grafts, estimated to be worth $100 million a year. Lombard Medical's commercial partner has the sales infrastructure to maximise the potential of Aorfix(TM) in Japan. The identity of the commercial partner has not been disclosed at this stage for reasons of commercial confidentiality.

Lombard Medical's Japanese partner will apply for marketing approval of Aorfix(TM) in Japan and once this is obtained, the commercial partner and Lombard Medical have agreed to a mutually exclusive contract to sell Aorfix(TM) in Japan.

In order to assist Lombard Medical's funding of its various development projects, including its thoracic stent graft whose development is currently on hold, the Japanese partner has agreed to provide the Company with a loan facility of up to $5 million. The first part of the loan, for a total of $2.5 million, will be available to Lombard Medical at its option once FDA approval of Aorfix(TM) has been received. This loan may be increased to up to a total of $5 million subject to certain conditions requiring the approval of both parties. The loans are repayable at the end of the term of the agreement, but may be forgiven if the parties agree to a second distribution term.

Commenting on this agreement, Lombard Medical Chief Executive John Rush said:

"Japan represents the third largest market worldwide for endovascular AAA procedures and is one of the fastest growing. We are pleased to have an opportunity to launch Aorfix(TM) into this important market with such an excellent partner. "

- Ends -

About Lombard Medical

Lombard Medical Technologies PLC (AIM: LMT), is a medical device company focused on device solutions for the $1 billion dollar abdominal aortic aneurysm (AAA) repair market. AAA's are a balloon-like enlargement of the aorta which, if left untreated, may rupture and cause death. Approximately 4.5 million people are living with AAA's in the developed world and each year 600,000 new cases are diagnosed. The market for endovascular stent grafts for this application is expected to grow to $1.6 billion by 2015. The Company's lead product, Aorfix(TM), is an endovascular stent graft which has been specifically designed to solve the problems that exist in treating complex tortuous anatomy which is often present in advanced AAA disease. Aorfix(TM) is currently being commercialised in the EU, with a pivotal clinical trial nearing completion in the USA.

The Company is headquartered in Oxfordshire, with operations in Ayrshire and Phoenix, USA.

Further background on the Company can be found at www.lombardmedical.com.

For further information:

+---------------------------------------+------------------------+

[nod] 05/10/2010 10:36

I'll be tempted to pick some up if I can get them below 0.8

[webshares] 07/9/2010 17:58

extra 200k in the bank, oh, well by the end of 2012 anyway. i'm not complaining, cheers scotland